Mifamurtide (Mepact)

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search

Mechanism of action

Fully synthetic derivative of muramyl dipeptide (MDP)

Diseases for which it is used

History of changes in EMA indication

  • 2009-03: Initial marketing authorisation

Also known as

  • Brand name: Mepact
Retrieved from "https://hemonc.org/w/index.php?title=Mifamurtide_(Mepact)&oldid=90143"